Source: MarketScreener

BrainQ: First Patient Enrolled in BrainQ's Pivotal Trial, EMAGINE , for Frequency-Tuned Electromagnetic Field Therapy to Reduce Disability Following Ischemic Stroke

(marketscreener.com) WASHINGTON, Dec. 9, 2021 /PRNewswire/ -- BrainQ today announced that the first patient has been enrolled at MedStar National Rehabilitation Hospital in its pivotal, randomized, double-blind, multicenter trial, EMAGINE . The trial is evaluating its frequency-tuned electromagnetic field treatment in facilitating recovery in individuals with...https://www.marketscreener.com/news/latest/First-Patient-Enrolled-in-BrainQ-s-Pivotal-Trial-EMAGINE-trade-for-Frequency-Tuned-Electromagneti--37273629/?utm_medium=RSS&utm_content=20211209

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Yotam Drechsler's photo - Co-Founder & CEO of BrainQ

Co-Founder & CEO

Yotam Drechsler

CEO Approval Rating

90/100

Read more